Natural splicing of exon 2 of human interleukin-15 receptor α-chain mRNA results in a shortened form with a distinct pattern of expression

被引:80
作者
Dubois, S [1 ]
Magrangeas, F [1 ]
Lehours, P [1 ]
Raher, S [1 ]
Bernard, J [1 ]
Boisteau, O [1 ]
Leroy, S [1 ]
Minvielle, S [1 ]
Godard, A [1 ]
Jacques, Y [1 ]
机构
[1] Inst Biol, INSERM, U463, Grp Rech Cytokines & Recepteurs, F-44035 Nantes 01, France
关键词
D O I
10.1074/jbc.274.38.26978
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the existence of eight different interleukin-15 receptor alpha-chain (IL-15R alpha) transcripts resulting from exon-splicing mechanisms within the IL-15R alpha gene. Two main classes of transcripts can be distinguished that do or do not (Delta 2 isoforms) contain the exon 2-coding sequence. Both classes were expressed in numerous cell lines and tissues (including peripheral blood lymphocytes) art comparable levels and could be transcribed in COS-7 cells, and the proteins were expressed at the cell surface. Both receptor forms displayed numerous glycosylation stales, reflecting differential usage of a single N-glycosylation site as well as extensive O-glycosylations. Whereas IL-15R alpha bound IL-15 with high affinity, Delta 2IL-15R alpha was unable to bind IL-15, thus revealing the indispensable role of the exon 2-encoded domain in cytokine binding. A large proportion of IL-15R alpha was expressed at the nuclear membrane with some intranuclear localization, supporting a potential direct action of the IL-15 IL-15R alpha complex at the nuclear level. In sharp contrast, Delta 2IL-15R alpha was found only in the non-nuclear membrane compartments, indicating that the exon alpha-encoded domain (which is shown to contain a potential nuclear localization signal) plays an important role in receptor post-translational routing. Together, our data indicate that exon 2 splicing of human IL-15R alpha is a natural process that might play regulatory roles at different levels.
引用
收藏
页码:26978 / 26984
页数:7
相关论文
共 32 条
  • [1] ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
  • [2] ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
  • [3] MOLECULAR-CLONING OF 2 CD7 (T-CELL LEUKEMIA ANTIGEN) CDNAS BY A COS CELL EXPRESSION SYSTEM
    ARUFFO, A
    SEED, B
    [J]. EMBO JOURNAL, 1987, 6 (11) : 3313 - 3316
  • [4] A LYMPHOKINE, PROVISIONALLY DESIGNATED INTERLEUKIN-T AND PRODUCED BY A HUMAN ADULT T-CELL LEUKEMIA LINE, STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    BURTON, JD
    BAMFORD, RN
    PETERS, C
    GRANT, AJ
    KURYS, G
    GOLDMAN, CK
    BRENNAN, J
    ROESSLER, E
    WALDMANN, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4935 - 4939
  • [5] INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR
    CARSON, WE
    GIRI, JG
    LINDEMANN, MJ
    LINETT, ML
    AHDIEH, M
    PAXTON, R
    ANDERSON, D
    EISENMANN, J
    GRABSTEIN, K
    CALIGIURI, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1395 - 1403
  • [6] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [7] CULLEN BR, 1988, J BIOL CHEM, V263, P4900
  • [8] IMMUNOLOGICAL CHARACTERIZATION OF ANTIGENIC DOMAINS ON HUMAN IL-2 RECEPTOR-BETA SUBUNIT - EPITOPE-FUNCTION RELATIONSHIPS
    FRANCOIS, C
    SOREL, M
    CHEREL, M
    BRAILLY, H
    MINVIELLE, S
    BLANCHARD, D
    JACQUES, Y
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (08) : 1173 - 1181
  • [9] IL-15, A NOVEL T-CELL GROWTH-FACTOR THAT SHARES ACTIVITIES AND RECEPTOR COMPONENTS WITH IL-2
    GIRI, JG
    ANDERSON, DM
    KUMAKI, S
    PARK, LS
    GRABSTEIN, KH
    COSMAN, D
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) : 763 - 766
  • [10] IDENTIFICATION AND CLONING OF A NOVEL IL-15 BINDING-PROTEIN THAT IS STRUCTURALLY RELATED TO THE ALPHA-CHAIN OF THE IL-2 RECEPTOR
    GIRI, JG
    KUMAKI, S
    AHDIEH, M
    FRIEND, DJ
    LOOMIS, A
    SHANEBECK, K
    DUBOSE, R
    COSMAN, D
    PARK, LS
    ANDERSON, DM
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3654 - 3663